Understand the offer
The word “peptide” is only the start.
Peptides are short chains of tiny parts, the same parts found in proteins.
Insulin, for instance, is a peptide. The word describes a kind of substance, rather than one treatment.
In US care, as of September 26, 2026, the rules depend on the exact medicine and whether FDA has approved it.
Medicines with FDA approval
FDA is the US Food and Drug Administration; its approval means it has reviewed evidence for a named medicine and what it treats.
As of September 26, 2026, US-approved medicines include Ozempic and Wegovy, which contain semaglutide, plus Mounjaro and Zepbound, which contain tirzepatide.
These medicines are often called GLP-1 drugs; they act like the body's own substances that help control appetite and blood sugar.
Get the product’s precise name, then ask which health concern it is meant to address for you.
Medicines made to order
When a pharmacist or doctor makes or mixes medicine for one patient’s particular need, the process is called compounding.
Under US rules as of September 26, 2026, meeting the required conditions can make compounding lawful.
Compounded medicines are not FDA approved; before patients get them, FDA does not review their quality, safety or how well they work.
Ask why an approved medicine would leave your need unmet, and get the name of the pharmacy making this version.
Products labeled for research
FDA warns, as of September 26, 2026, that weight-loss products labeled for research may cause harm and their quality is unknown.
FDA has sent sellers letters saying they broke the law by offering unapproved drugs as treatments, even with a “for research” label.
When these injections were in short supply, pharmacies could make copies under rules meant for that shortage.
As of September 26, 2026, FDA no longer listed semaglutide and tirzepatide injections as being in short supply.
Pharmacies can no longer use that shortage as the reason to keep making copies of these medicines.
A pharmacy-made version may still be allowed when the person who prescribes it judges that the change makes an important medical difference for that patient.
A lower price is not enough to meet this rule; the pharmacy also has to meet the other legal conditions.
As of September 26, 2026, FDA says adding a vitamin to an otherwise similar shot may still leave it under the rules for copies.
Ask: “What need does this pharmacy-made medicine meet that the approved medicine cannot? Why is this version allowed for me?”
Find care you can check
Start with a license and a real conversation.
Care may begin at a clinic visit or through telehealth. A telehealth visit takes place from a distance, through online messages or calls by phone or video.
As of September 26, 2026, a telehealth clinician needs a license or other permission for care in whichever state you are physically in during the visit.
States differ on whether answering a set of website questions can be enough for someone to decide on treatment.
Ask: “Is this form enough under my state's rules, or do I need a conversation or an exam before treatment?”
Check the person
Doctors receive their licenses from a state office called a medical board. The board’s records are public; they list a doctor’s license status and any actions it has taken against the doctor.
Ask who will write your prescription. Get that person's full name, job title and license details. If that person is not a doctor, ask which state office keeps their license record.
Find a state medical boardCheck the pharmacy
The state board of pharmacy is a separate office that licenses pharmacies and keeps their records.
Find out which pharmacy is preparing the medicine or sending it to you. Search that name in your state's records.
If an online pharmacy has no listing in your state pharmacy board’s license records, FDA advises against using it.
Open FDA's pharmacy lookupAs of September 26, 2026, calling a clinic or medicine “FDA registered” says nothing about whether FDA has approved it.
A license record confirms a license; it does not prove the quality of the care or the product.
Before the visit
Note what brought you here, how long it has been a concern, and the change you would like to see. List the medicines and supplements you take and bring those notes.
In the conversation
Ask why this treatment fits your concern, what else could help, and how progress would be judged.
Medical-board advice requires a doctor to set up any necessary tests or an exam in person if a remote visit cannot provide enough information.
Ask: “Can you learn enough from this visit, or do I need tests or an exam in person?”
Before agreeing
Get the proposed medicine, pharmacy, total charges and follow-up plan in writing. Ask who answers questions between visits.
Know the whole bill
Ask for the cost after the offer ends.
Get a quote on paper with separate charges for medicine, visits, tests and shipping. Ask what repeats, what changes and how to stop a membership.
A check on September 26, 2026 covered six national online weight-care services; services with advertised monthly fees listed medicine as an extra cost.
That small check cannot tell you what the service you are considering will charge. Ask whether its fee includes the medicine.
A cash-price example · Medicine only
The Wegovy pen offer
As of September 26, 2026, a Wegovy pen cash offer priced the first two monthly fills at $199 each.
This price was only for new patients whose prescribed pen contained one of the lower amounts of medicine, through December 31, 2026.
Later monthly prices were $349, or $399 for the pen containing more semaglutide, called Wegovy HD.
Ask the pharmacy whether your prescription qualifies for the offer and what you will pay for later refills.
Read the government price listingUse an offer like this to ask better questions about the full bill. It does not decide which medicine fits your care.
Ask your insurance plan directly
Does it pay for the named medicine for your diagnosed condition? What would you pay yourself?
A formulary lists the medicines an insurance plan covers.
With prior authorization, the insurer must approve payment first; only then can the pharmacy fill the prescription.
If you use Medicare
Medicare covers certain weight-loss medicines through its temporary GLP-1 Bridge program.
People who qualify for this program pay $50 out of their own pocket for a monthly supply of medicine, as of September 26, 2026.
CMS, the agency running Medicare, lists the program dates as July 1, 2026 through December 31, 2027.
This program is separate from Part D, Medicare’s usual insurance for prescription medicines.
Each year, Part D sets a limit on what you pay from your own pocket for covered medicines.
Your $50 Bridge payment does not count toward that yearly Part D limit.
You could pay the Bridge charges as well as reach your Part D plan’s yearly limit.
Ask your drug plan to check whether you qualify and explain your likely total costs. Ask how your health conditions and past coverage affect the answer.
Read Medicare's eligibility guideBefore treatment
Make room for your health questions.
If your search began with weight changes, tiredness or menopause concerns, put that concern at the top of your notes. Ask what else might explain it.
Bring up pregnancy plans, breastfeeding and any birth control you use early. Ask how each matters for the medicine being discussed.
Pregnancy advice differs by medicine
The Ozempic label checked on September 17, 2026 says to end treatment two months or more before a planned pregnancy.
The Zepbound label checked on September 17, 2026 says to stop treatment when a pregnancy is found.
Discuss these label instructions with the person treating you. Ask for a plan for your own situation.
As of September 17, 2026, pharmacy-made medicines had no pregnancy or breastfeeding information reviewed by FDA like the information on approved medicine labels.
Ask what is known about the exact medicine offered to you, rather than assuming a brand's label answers the question for a pharmacy-made version.
Pause until the main questions have answers
- As of September 26, 2026, under US federal law, a prescription medicine cannot be dispensed until there is a valid prescription.
- FDA calls claims that a compounded medicine is approved, or proven to match the approved product, false or misleading.
- FDA flags a service as concerning when no licensed doctor is available for questions once the medicine has arrived.
By September 26, 2026, FDA had reports of mistakes with the amount of pharmacy-made semaglutide taken, which may have led to hospital stays.
If the label’s directions are unclear, get an explanation from your prescriber or pharmacist. Ask who can help if the package or written plan differs from what was agreed.
MedWatch is FDA’s reporting service, where patients can send reports about problems with medicines.
Open FDA MedWatchTake the next conversation slowly
You do not need a peptide picked out.
Open the conversation by naming the concern that matters to you. These prompts leave room for an explanation before a decision.
- Which health concern would this treatment address, and what other causes might explain it?
- Why this medicine? What are the other options, including no medicine?
- What evidence fits someone in my situation?
- How does this fit with my other medicines, birth control or pregnancy plans?
- Who writes my prescription, and which pharmacy makes or sends the medicine?
- What is the total ongoing cost, and how do I cancel?
- How will we judge progress, and who answers questions between visits?
A useful next step is a clear question, a checked license and a written explanation you can read at your own pace.
Open the source behind the answer
Read the parts that matter to your decision.
FDA · Patient explanation
What compounding changes
See what sets a medicine made to order apart from a product FDA has reviewed.
Read the compounding answersFDA · Supply and rules
Copies after a shortage
Read when a pharmacy may make its own semaglutide or tirzepatide medicine after the shortage ends, including versions with a vitamin added.
Read the supply updatesFDA · Online care
Claims worth questioning
For the agency's concerns about compounded weight medicines and online treatment offers.
Read FDA's concernsMedical boards · Guidance
What a phone or online visit needs
Read the medical boards' advice on checking your health, letting you ask questions and deciding whether a treatment fits you.
Read the advice on online visits (PDF)DailyMed · Medicine label
Semaglutide and pregnancy
Open the Ozempic label for its pregnancy section, then bring your questions to the person writing your prescription.
Open the Ozempic labelDailyMed · Medicine label
Tirzepatide and pregnancy
Open the Zepbound label to read what it says about pregnancy and breastfeeding for that medicine.
Open the Zepbound label